Response to commentary by Andrew Sharp et al.

IF 3.3 2区医学 Q1 PERIPHERAL VASCULAR DISEASE Journal of Hypertension Pub Date : 2024-12-01 Epub Date: 2024-10-31 DOI:10.1097/HJH.0000000000003877

Franz H Messerli, Renate Schoenenberger-Berzins, Adrian W Messerli

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

对安德鲁-夏普等人的评论的回应

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Hypertension 医学-外周血管病

CiteScore

7.90

自引率

6.10%

发文量

1389

审稿时长

3 months

期刊介绍： The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.

期刊最新文献

Response to commentary by Andrew Sharp et al. Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement. Abnormal brain-heart electrophysiology in mild and severe orthostatic hypotension. Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats. Aortic reservoir-excess pressure parameters are associated with worse cognitive function in people with untreated stage II/III hypertension.